BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 24948737)

  • 1. Molecular basis for disruption of E-cadherin adhesion by botulinum neurotoxin A complex.
    Lee K; Zhong X; Gu S; Kruel AM; Dorner MB; Perry K; Rummel A; Dong M; Jin R
    Science; 2014 Jun; 344(6190):1405-10. PubMed ID: 24948737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multivalency effects of hemagglutinin component of type B botulinum neurotoxin complex on epithelial barrier disruption.
    Amatsu S; Matsumura T; Yutani M; Fujinaga Y
    Microbiol Immunol; 2018 Feb; 62(2):80-89. PubMed ID: 29266585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional dissection of the Clostridium botulinum type B hemagglutinin complex: identification of the carbohydrate and E-cadherin binding sites.
    Sugawara Y; Yutani M; Amatsu S; Matsumura T; Fujinaga Y
    PLoS One; 2014; 9(10):e111170. PubMed ID: 25340348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Botulinum Hemagglutinin: Critical Protein for Adhesion and Absorption of Neurotoxin Complex in Host Intestine.
    Amatsu S; Fujinaga Y
    Methods Mol Biol; 2020; 2132():183-190. PubMed ID: 32306327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crystal structure of Clostridium botulinum whole hemagglutinin reveals a huge triskelion-shaped molecular complex.
    Amatsu S; Sugawara Y; Matsumura T; Kitadokoro K; Fujinaga Y
    J Biol Chem; 2013 Dec; 288(49):35617-25. PubMed ID: 24165130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional Analysis of Botulinum Hemagglutinin (HA).
    Matsumura T; Fujinaga Y
    Methods Mol Biol; 2020; 2132():191-200. PubMed ID: 32306328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibiting oral intoxication of botulinum neurotoxin A complex by carbohydrate receptor mimics.
    Lee K; Lam KH; Kruel AM; Mahrhold S; Perry K; Cheng LW; Rummel A; Jin R
    Toxicon; 2015 Dec; 107(Pt A):43-9. PubMed ID: 26272706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The botulinum toxin complex meets E-cadherin on the way to its destination.
    Sugawara Y; Fujinaga Y
    Cell Adh Migr; 2011; 5(1):34-6. PubMed ID: 20935473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular engineering of a minimal E-cadherin inhibitor protein derived from Clostridium botulinum hemagglutinin.
    Amatsu S; Matsumura T; Zuka M; Fujinaga Y
    J Biol Chem; 2023 Mar; 299(3):102944. PubMed ID: 36707052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disruption of the epithelial barrier by botulinum haemagglutinin (HA) proteins - differences in cell tropism and the mechanism of action between HA proteins of types A or B, and HA proteins of type C.
    Jin Y; Takegahara Y; Sugawara Y; Matsumura T; Fujinaga Y
    Microbiology (Reading); 2009 Jan; 155(Pt 1):35-45. PubMed ID: 19118344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Botulinum neurotoxin A complex recognizes host carbohydrates through its hemagglutinin component.
    Yao G; Lee K; Gu S; Lam KH; Jin R
    Toxins (Basel); 2014 Feb; 6(2):624-35. PubMed ID: 24525478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Mechanism of intestinal absorption of botulinum neurotoxin complex].
    Matsumura T
    Nihon Saikingaku Zasshi; 2019; 74(3):167-175. PubMed ID: 31787706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Botulinum hemagglutinin disrupts the intercellular epithelial barrier by directly binding E-cadherin.
    Sugawara Y; Matsumura T; Takegahara Y; Jin Y; Tsukasaki Y; Takeichi M; Fujinaga Y
    J Cell Biol; 2010 May; 189(4):691-700. PubMed ID: 20457762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural and biochemical characterization of the protease domain of the mosaic botulinum neurotoxin type HA.
    Lam KH; Sikorra S; Weisemann J; Maatsch H; Perry K; Rummel A; Binz T; Jin R
    Pathog Dis; 2018 Jun; 76(4):. PubMed ID: 29688327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Botulinum toxin A complex exploits intestinal M cells to enter the host and exert neurotoxicity.
    Matsumura T; Sugawara Y; Yutani M; Amatsu S; Yagita H; Kohda T; Fukuoka S; Nakamura Y; Fukuda S; Hase K; Ohno H; Fujinaga Y
    Nat Commun; 2015 Feb; 6():6255. PubMed ID: 25687350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel subunit structure of Clostridium botulinum serotype D toxin complex with three extended arms.
    Hasegawa K; Watanabe T; Suzuki T; Yamano A; Oikawa T; Sato Y; Kouguchi H; Yoneyama T; Niwa K; Ikeda T; Ohyama T
    J Biol Chem; 2007 Aug; 282(34):24777-83. PubMed ID: 17581814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel function of botulinum toxin-associated proteins: HA proteins disrupt intestinal epithelial barrier to increase toxin absorption.
    Fujinaga Y; Matsumura T; Jin Y; Takegahara Y; Sugawara Y
    Toxicon; 2009 Oct; 54(5):583-6. PubMed ID: 19073205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of Hemagglutinin Negative Botulinum Progenitor Toxins.
    Kalb SR; Baudys J; Smith TJ; Smith LA; Barr JR
    Toxins (Basel); 2017 Jun; 9(6):. PubMed ID: 28617306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High resolution crystal structures of Clostridium botulinum neurotoxin A3 and A4 binding domains.
    Davies JR; Rees J; Liu SM; Acharya KR
    J Struct Biol; 2018 May; 202(2):113-117. PubMed ID: 29288126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Translocation and dissemination of botulinum neurotoxin from the intestinal tract.
    Fujinaga Y; Popoff MR
    Toxicon; 2018 Jun; 147():13-18. PubMed ID: 29074396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.